Christopher Robert BEBBINGTON,Bradford Andrew YOUNGBLOOD,Nenad TOMASEVIC
申请号：
US16610480
公开号：
US20200148766A1
申请日:
2018.05.04
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure provides methods for the treatment of an allergic ocular disease (e.g., allergic conjunctivitis, keratoconjunctivitis, or giant papillary conjunctivitis). In particular, the present disclosure provides methods for the treatment of an allergic ocular disease through administration of antibodies that bind to human Siglec-8 or compositions comprising said antibodies. The present disclosure also provides articles of manufacture or kits comprising antibodies that bind to human Siglec-8 for the treatment of an allergic ocular disease.
